$KRTL Holding Group Congratulates SIGMA on National Recognition for Pharmaceutical Excellence in Bolivia
https://www.otcmarkets.com/stock/KRTL/news/KR...?id=498009
KRTL Holding Group Inc. (OTC: KRTL) ("KRTL" or the "Company"
extends its congratulations to its partner and majority-owned subsidiary, Industria Químico-Farmacéutica SIGMA Corp., on receiving national recognition from the Bolivian Chamber of Commerce and Industry (ICAMC) for its outstanding contributions to the pharmaceutical manufacturing sector.
The distinction was awarded as part of Bolivia's "Hecho en Bolivia" ("Made in Bolivia" campaign, which highlights companies that represent the nation through quality manufacturing, innovation, and a sustained commitment to excellence. The recognition reaffirms SIGMA’s leadership in advancing pharmaceutical production that aligns with both local public health priorities and international quality standards.
"This recognition reaffirms the decades of leadership and impact that SIGMA has delivered to the people of Bolivia," said Cesar Herrera, CEO of KRTL Holding Group Inc. "We are proud to work alongside a company that exemplifies what it means to serve both local communities and international markets."
Guided by the leadership of Patricia Wilstermann, SIGMA has consistently demonstrated excellence across five decades in Bolivia's pharmaceutical sector. The company’s facility in Cochabamba adheres to globally recognized Good Manufacturing Practices (GMP), positioning SIGMA to support both local healthcare delivery and international distribution efforts as part of its integration with KRTL Biotech, Inc.
The honor was publicly shared by ICAMC via LinkedIn and can be viewed here: https://www.linkedin.com/posts/icamcbba_hecho...60800-3MgA
"SIGMA has always worked with integrity and purpose, and this recognition belongs to our entire team," said Patricia Wilstermann, CEO of SIGMA Corp. "We remain committed to building a pharmaceutical sector in Bolivia that delivers trust, efficacy, and innovation."
KRTL Holding views this recognition as a further validation of its strategic merger and its vision to bring South American pharmaceutical excellence into new global markets through collaborative partnerships, regulatory alignment, and investment in regional capabilities.
https://www.otcmarkets.com/stock/KRTL/news/KR...?id=498009
KRTL Holding Group Inc. (OTC: KRTL) ("KRTL" or the "Company"
extends its congratulations to its partner and majority-owned subsidiary, Industria Químico-Farmacéutica SIGMA Corp., on receiving national recognition from the Bolivian Chamber of Commerce and Industry (ICAMC) for its outstanding contributions to the pharmaceutical manufacturing sector. The distinction was awarded as part of Bolivia's "Hecho en Bolivia" ("Made in Bolivia"
campaign, which highlights companies that represent the nation through quality manufacturing, innovation, and a sustained commitment to excellence. The recognition reaffirms SIGMA’s leadership in advancing pharmaceutical production that aligns with both local public health priorities and international quality standards. "This recognition reaffirms the decades of leadership and impact that SIGMA has delivered to the people of Bolivia," said Cesar Herrera, CEO of KRTL Holding Group Inc. "We are proud to work alongside a company that exemplifies what it means to serve both local communities and international markets."
Guided by the leadership of Patricia Wilstermann, SIGMA has consistently demonstrated excellence across five decades in Bolivia's pharmaceutical sector. The company’s facility in Cochabamba adheres to globally recognized Good Manufacturing Practices (GMP), positioning SIGMA to support both local healthcare delivery and international distribution efforts as part of its integration with KRTL Biotech, Inc.
The honor was publicly shared by ICAMC via LinkedIn and can be viewed here: https://www.linkedin.com/posts/icamcbba_hecho...60800-3MgA
"SIGMA has always worked with integrity and purpose, and this recognition belongs to our entire team," said Patricia Wilstermann, CEO of SIGMA Corp. "We remain committed to building a pharmaceutical sector in Bolivia that delivers trust, efficacy, and innovation."
KRTL Holding views this recognition as a further validation of its strategic merger and its vision to bring South American pharmaceutical excellence into new global markets through collaborative partnerships, regulatory alignment, and investment in regional capabilities.
